Position in PHVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$25,935,000
-$2,315,000 QoQ
Shares Held
750,000
-25.0% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#20
of 124 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. PHVS ranks #23 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
640,000 | $214,265,600 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $136,234,886 | |
| 3 | PBLS |
Parabilis Medicines, Inc.
|
4,615,612 | $126,329,300 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
|
2,657,521 | $110,738,900 | |
| 5 | ERAS |
Erasca, Inc.
|
6,000,000 | $109,920,000 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
2,510,000 | $101,981,300 | |
| 7 | EYPT |
EyePoint, Inc.
|
7,000,000 | $100,100,000 | |
| 8 | ALMS |
Alumis Inc.
|
3,285,596 | $92,456,671 |
All Filings in PHVS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,935,000 | 750,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $28,250,000 | 1,000,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,053,250 | 1,083,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $34,011,840 | 1,363,200 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,602,016 | 1,454,660 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,023,422 | 1,466,460 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $28,112,038 | 1,466,460 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $27,158,839 | 1,466,460 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $27,569,448 | 1,466,460 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,551,840 | 1,711,460 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $48,006,453 | 1,711,460 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $28,413,670 | 1,361,460 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,740,515 | 973,614 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,576,585 | 816,460 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,185,175 | 816,460 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,261,525 | 1,207,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,325,561 | 1,145,953 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,420,443 | 684,888 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $9,925,229 | 689,731 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,228,930 | 689,731 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,876,797 | 744,863 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $24,178,721 | 864,143 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||